You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Follicular

Showing 1 - 25 of 3,129
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Patients Undergoing Follicular Lymphoma Clinical Research

Not yet recruiting
  • Follicular Lymphoma
    • San Francisco, California
      Power Life Sciences
    Sep 15, 2023

    Follicular Lymphoma Trial in New York (Mosunetuzumab, Tazemetostat Pill)

    Not yet recruiting
    • Follicular Lymphoma
    • New York, New York
      Weill Cornell Medicine/NewYork-Presbyterian Hospital
    Aug 8, 2023

    Follicular Lymphoma, Refractory Follicular Lymphoma Trial (Tazverik (Tazemetostat))

    Not yet recruiting
    • Follicular Lymphoma
    • Refractory Follicular Lymphoma
    • Tazverik (Tazemetostat)
    • (no location specified)
    Oct 6, 2023

    Hürthle Cell Carcinoma and Follicular Thyroid Carcinoma

    Completed
    • Huerthle Cell Carcinoma
      • (no location specified)
      Jul 20, 2023

      Alopecia Scar Trial (follicular unit extraction and implantaion)

      Not yet recruiting
      • Alopecia Scar
      • follicular unit extraction and implantaion
      • (no location specified)
      Nov 22, 2023

      Lymphoma, Follicular Trial (Mosunetuzumab)

      Not yet recruiting
      • Lymphoma, Follicular
      • (no location specified)
      May 8, 2023

      Glomerulonephritis, IGA Trial in Besançon (Blood collection, Urine sample)

      Not yet recruiting
      • Glomerulonephritis, IGA
      • Blood collection
      • Urine sample
      • Besançon, France
        Centre Hospitalier Universitaire de Besançon
      Mar 17, 2023

      Follicular Lymphoma Stage II, Follicular Lymphoma Stage III, Follicular Lymphoma Stage IV Trial in Australia (BMS-986369,

      Not yet recruiting
      • Follicular Lymphoma Stage II
      • +2 more
      • Ballarat, Victoria, Australia
      • +4 more
      Mar 15, 2023

      Follicular Lymphoma Trial in Shanghai (lenalidomide, rituximab, parsaclisib)

      Not yet recruiting
      • Follicular Lymphoma
      • Shanghai, Shanghai, China
        Ruijin hospital, school of medicine, Shanghai jiao tong universi
      May 10, 2023

      Follicular Lymphoma, Tumor Trial in Houston (Obinutuzumab, CC-99282)

      Not yet recruiting
      • Follicular Lymphoma
      • Tumor
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 30, 2023

      Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage III Follicular Lymphoma, Ann Arbor Stage IV Follicular Lymphoma Trial in

      Recruiting
      • Ann Arbor Stage II Follicular Lymphoma
      • +5 more
      • Fresno, California
      • +2 more
      Jan 24, 2023

      Obinutuzumab-based Therapy for Previously Untreated FL

      Recruiting
      • Follicular Lymphoma
      • Shanghai, Shanghai, China
        Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
      Jun 3, 2023

      Follicular Lymphoma, Low Grade Non-Hodgkin's Lymphoma, Adult Trial in Boston (Epcoritamab, Rituximab)

      Not yet recruiting
      • Follicular Lymphoma
      • Low Grade Non-Hodgkin's Lymphoma, Adult
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Mar 13, 2023

      Obinutuzumab in Combination With Lenalidomide in Relapsed or

      Recruiting
      • Follicular Lymphoma
        • Tianjin, China
          Institute of Hematology and Blood Diseases Hospital ,Chinese Aca
        Apr 27, 2023

        Human Follicular Fluid Markers and Reproductive Outcomes in IVF

        Not yet recruiting
        • IVF
        • Infertility
        • Natural cycle In Vitro Fertilisation (IVF)
        • +4 more
        • (no location specified)
        May 30, 2023

        Follicular Lymphoma (FL) Trial (biological, drug, other)

        Not yet recruiting
        • Follicular Lymphoma (FL)
        • Tisagenlecleucel
        • +4 more
        • (no location specified)
        May 24, 2023

        Follicular Lymphoma, Non-Hodgkin's Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Rituximab, Copanlisib)

        Recruiting
        • Follicular Lymphoma
        • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 25, 2023

        Follicular Lymphoma Trial in Australia (Opdivo)

        Active, not recruiting
        • Follicular Lymphoma
        • Ballarat, Victoria, Australia
        • +4 more
        Jan 30, 2023

        Follicular Lymphoma Trial (Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine phosphate)

        Not yet recruiting
        • Follicular Lymphoma
        • Axicabtagene Ciloleucel
        • +5 more
        • (no location specified)
        Sep 21, 2023

        Follicular Lymphoma, Marginal Zone Lymphoma, Indolent Non-hodgkin Lymphoma Trial in Boston (Obinutuzumab, Glofitamab)

        Not yet recruiting
        • Follicular Lymphoma
        • +2 more
        • Boston, Massachusetts
          Dana-Farber Cancer Institute
        Mar 13, 2023

        Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann

        Active, not recruiting
        • Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma
        • +11 more
        • Washington, District of Columbia
        • +6 more
        Feb 2, 2023

        Lymphoma, Follicular, Follicular Lymphoma Trial in Saint Louis (Mosunetuzumab, Polatuzumab vedotin)

        Recruiting
        • Lymphoma, Follicular
        • Follicular Lymphoma
        • Saint Louis, Missouri
          Washington University School of Medicine
        Nov 14, 2022

        Follicular Lymphoma (FL) Trial in Noblesville (Odronextamab, Rituximab, Cyclophosphamide)

        Recruiting
        • Follicular Lymphoma (FL)
        • Noblesville, Indiana
          Investigative Clinical Research of Indiana
        Oct 18, 2023

        Relapsed Follicular Lymphoma, Refractory Follicular Lymphoma Trial in Boston (TAZEMETOSTAT, Zandelisib)

        Not yet recruiting
        • Relapsed Follicular Lymphoma
        • Refractory Follicular Lymphoma
        • Boston, Massachusetts
        • +1 more
        Oct 28, 2022

        Living Conditions of Diffuse Large B-Cell Lymphoma or Follicular

        Completed
        • Diffuse Large Cell Diffuse Lymphoma
        • Follicular Lymphoma
        • Questionnaires
        • Collection of clinical data and treatments
        • Dijon, France
          Chu Dijon Bourogne
        Jan 31, 2023